Edition:
United States

JSR Corp (4185.T)

4185.T on Tokyo Stock Exchange

1,902JPY
12:08am EDT
Change (% chg)

¥-4 (-0.21%)
Prev Close
¥1,906
Open
¥1,902
Day's High
¥1,911
Day's Low
¥1,892
Volume
522,600
Avg. Vol
1,323,742
52-wk High
¥2,115
52-wk Low
¥1,287

Latest Key Developments (Source: Significant Developments)

ARAKAWA CHEMICAL INDUSTRIES to buy OPSTAR business from JSR Corp
Monday, 1 Aug 2016 02:20am EDT 

ARAKAWA CHEMICAL INDUSTRIES <4968.T>:Says it will buy OPSTAR ( functional coating materials) business from JSR Corp <4185.T>, effective Oct. 1.  Full Article

R&I affirms JSR Corp's rating at "AA-" and changes outlook to negative from stable -R&I
Friday, 15 Jul 2016 02:35am EDT 

JSR Corp <4185.T> : Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I .Rating outlook changed to negative from stable.  Full Article

JSR Corporation reaches basic agreement with Ube Industries and Mitsubishi Rayon to start negotiation for merger of units in ABS resin business
Monday, 9 May 2016 02:35am EDT 

JSR Corporation <4185.T> and Ube Industries <4208.T> : Says JSR's wholly owned unit TPC to merge with UMG ABS, which is a JV of Ube Industries and Mitsubishi Rayon .Says the parties to sign agreement on Oct. 31 and merger effective Oct. 1, 2017.  Full Article

JSR to adopt International Financial Reporting Standards
Monday, 25 Apr 2016 02:00am EDT 

JSR CORP:Says to apply International Financial Reporting Standards (IFRS) as the new accounting method, to replace the current Japanese Accounting Standards.IFRS effective from July, 2017, when disclosing the financial report for Q1 of FY ending March 2018.  Full Article

JSR CORP establishes JSR Life Sciences Division
Monday, 18 Apr 2016 10:11am EDT 

JSR CORP:Says formation and establishment of its Life Sciences Division, JSR Life Sciences.  Full Article

JSR lowers consolidated full-year outlook for FY 2016
Monday, 11 Apr 2016 04:00am EDT 

JSR CORP:Says the company lowered the consolidated full-year outlook for revenue to 385,000 mln yen from 400,000 mln yen for the fiscal year ended March 31, 2016.Sees a decrease of operating profit forecast to 34,000 mln yen from 41,000 mln yen.Sees a decrease of ordinary profit forecast to 33,000 mln yen from 39,500 mln yen.Sees a decrease of net profit forecast to 24,000 mln yen from 30,000 mln yen.Sees a decrease of earnings per share to 105.57 yen from 131.06 yen.Comments the decreased sale volume, sluggish market condition and deteriorating margins in elastomer business and extraordinary loss recorded as impairment loss are the main reasons for the forecast.  Full Article

JSR announces to retire treasury shares
Monday, 26 Oct 2015 02:00am EDT 

JSR CORP:To retire 11,898,660 shares (5 pct stake) of its common stock on Nov. 2.Says the total shares outstanding will be 226,074,545 shares after the retirement.  Full Article

JSR cancels business and capital alliance with Tri Chemical Laboratories
Tuesday, 13 Oct 2015 03:00am EDT 

JSR CORP:Cancelled a business and capital alliance with Tri Chemical Laboratories Inc. on Oct. 13.The business and capital alliance was signed on March 9, 2009.Cancellation takes effective on Oct. 13.  Full Article

Tri Chemical Laboratories announces changes in shareholding structure by JSR
Tuesday, 13 Oct 2015 03:00am EDT 

Tri Chemical Laboratories Inc:Says JSR decreased stake in the company to 0 pct (0 voting rights) from 18.93 pct (14,479 voting rights).  Full Article

JSR acquires shares of Medical&Biological Laboratories
Monday, 5 Oct 2015 03:30am EDT 

JSR CORP:Says acquired 51,000 shares (0.20 pct voting rights) in Medical&Biological Laboratories at price of 29,519,000 yen.Says increased voting rights in Medical&Biological Laboratories to 50.01 pct (12,906,906 shares) from 49.81 pct (12,855,906 shares).Effective Oct. 2.  Full Article

More From Around the Web